Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab in Stage III Colon Cancer
NCT00079274Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2004
- Primary completion
- Nov 2012
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 3 trial of KL-140 in colon cancer, sponsored by National Cancer Institute. Started Feb 2004; status: completed.
02
Drugs
KL-140
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00079274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00079274.